iGATE RESEARCH report titled “Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020” is a 150 page report with 74 Figures and 10 Tables. This report analyses the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer’s Disease - Country Wise Drugs Market, Country Wise Alzheimer’s Disease Prevalence, Major Deals in Alzheimer’s Disease Drugs Market Landscape, Funding in Alzheimer’s Disease Drugs Research, Driving Factors and Challenges for Alzheimer’s Disease Drugs Market. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20Alzheimers%20Disease%20Drugs%20Market%20Analysis Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com
China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025. Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market. Access full Research: https://www.renub.com/china-cancer-drugs-market-p.php
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and Orphan Drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry. With close to 65-70 Million people in the US & Europe having some kind of rare disease complaints, the increasing activities around the development of orphan drugs only imply that the appropriate treatments for unmet needs are increasing, thus increasing the profit margins in the future. Complete report is spread across 1690 pages is available @ http://www.reportsnreports.com/reports/271801-global-orphan-drug-pipeline-analysis.html .
Big Market Research “Respiratory Drugs Markets” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/respiratory-drugs-in-china-market China's demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
Big Market Research “Genome-Based Drug Markets” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. Visit for more info @ http://www.bigmarketresearch.com/genome-based-drug-in-china-market China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Big Market Research “Incretion Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2016. Visit for more info @ http://www.bigmarketresearch.com/incretion-drugs-in-china-market China's demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
iGATE RESEARCH report entitled “Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019” provides an in-depth analysis of the drugs, pipeline drugs and the key players that will shape the future of Hepatitis C Drugs Market. This 113 page report with 27 Figures and 1 Table studies the Hepatitis C Drug Market Landscape. This Report is analyzed from four view points: Approved drugs sales, Pipeline drugs sales, Company Wise Clinical Trial Analysis and Deals and Acquisitions in Hepatitis C Landscape. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Hepatitis%20C%20Drugs%20Market%20and%20Pipeline%20Analysis
Big Market Research “Allergy Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/allergy-drugs-in-china-market China's demand for Allergy Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Big Market Research “Cough Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/cough-drugs-in-china-market China's demand for Cough Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.
Big Market Research “Drug Delivery System Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/drug-delivery-system-in-china-market China's demand for Drug Delivery System has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Anesthesia drugs market research report specially focuses on ketamine market in USA such as propofol, midazolam & diazepam, fospropofol disodium and more.
The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE
This new 247-page report provides a comprehensive analysis of the French Therapeutic Drug Monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin. Complete report is available @ http://www.reportsnreports.com/reports/274303-2014-strategies-for-the-french-therapeutic-drug-monitoring-tdm-market.html .
Get more information about the market: http://bit.ly/2Fpkujz The Canada generic drugs market reached a value of US$ 6.0 Billion in 2017. Generic drug refers to a medication that has the same active ingredients and therapeutic effect as that of a branded drug. These drugs can be oral, intravenous, intramuscular, topical or inhalant. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=700&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter : @imarcglobal
Alzheimer’s disease drug market is on the curvature stage. Since 2003, there is not any single “magic bullet” launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.
The report on Biological Drugs Market by Infinium Global Research analyzes the Biological Drugs Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biological Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Biological Drugs Market.
"" Market Report on Human Drugs for Veterinary Use (Current Trends and Future Commercial Prospects for Crossover Drugs)"", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also called crossover drugs. A wide range of human drugs continue to be applied in the veterinary space due to a lack of approved animal therapies, convenience and the rising costs of veterinary research. To Know More: http://bit.ly/292oLEZ
Anti-Viral Drug Market By Application (HIV Treatment, Hepatitis Treatment, Herpes Treatment, Influenza Treatment, Others) By Type (Generic Drugs, Branded Drugs) By End User (Hospitals, Clinics, Others) and Region - Global Forecast 2016 to 2024.
The report on Gastrointestinal Drugs Market by Infinium Global Research analyzes over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Gastrointestinal Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Gastrointestinal Drugs Market.
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations.
The report on Antiviral Drugs Market by drug type(drugs and generic drugs), therapeutics(HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes therapeutics, influenza therapeutics and others), end user(hospitals, clinics and ambulatory surgical center) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Antiviral Drugs Market is projected to grow at a CAGR between 4.0 % to 4.5 % in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
This Report provided by 24 Market Reports is about, Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases.
The report on Biological Drugs Market by roduct Type (therapeutic protein -levemir, neulasta, eylea, novolog, enbrel, avonex, neupogen, humalog, victoza, lantus, epogen, aranesp; monoclonal antibody - avastin, humira, remicade; vaccine - gardasil, prenvar 13, fluzone) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biological Drugs Market is projected to grow at a CAGR between 10.0% to 10.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Veterinary Drugs Market by drug type (anti-infective, anti-inflammatory, paraciticides), by animal type (companion animal and livestock animal), by route of administration (Oral, Parenteral and topical) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Veterinary Drugs Market is projected to grow at a CAGR between 5.0 % to 5.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Blood Cancer Drugs Market by product (rituaxan/mabthera, gleevac/glivec, revlimid, velcade, tasigna, pomalyst, vidaza, kyprolis, adcetris, and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Blood Cancer Drugs Market is projected to grow at a CAGR between 10.5% to 11.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
This Future Market Insights (FMI) report examines the global injectable drug delivery market for the period 2018–2028. The primary objective of the report is to offer insights into market opportunity for the injectable drug delivery market.
The growing geriatric population and increasing incidences of chronic diseases are leading numerous government bodies to focus on reducing healthcare costs by promoting the manufacturing of generics. This, in turn, is primarily driving the generic drugs market. Furthermore, the rising number of drug patents expiring or about to expire is also providing a thrust to the global market. In addition to this, significant growth in the healthcare sector and several product innovations, such as the introduction of biosimilars, are further anticipated to fuel the generic drugs market in the coming years.
The launch of various favorable policies by government bodies aimed at spreading awareness towards the usage of modern medicines for HIV treatments and early detection is among the key factors driving the GCC HIV drugs market. Besides this, the widespread adoption of advanced medical solutions is propelling the demand for HIV drugs that aid the immune system in keeping the levels of the virus at a minimal level, thereby leading to prolonged life expectancy in patients.
Diabetes is a health disorder in which the level of blood glucose gets elevated in the human body. Global Diabetes Drugs Market is projected to go beyond US$ 76 Billion by the end of the year 2024. Type 1 Diabetes: Type 1 diabetes also known by the name of juvenile or childhood-onset or insulin-dependent diabetes is characterized by the deficient insulin production and needs insulin administration daily. Type 2 Diabetes: Type 2 diabetes formerly known as adult-onset or non-insulin dependent diabetes results from the human body’s ineffective use of insulin. For More Information: https://www.renub.com/global-diabetes-drug-market-nd.php Contact Us Email: info@renub.com Phone: +1-678-302-0700 Web: www.renub.com
The report analyses the Antiretroviral Market By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors, and Others). The report analyses the antiretroviral market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and South Africa) for the historical period of 2013-2017 and the forecast period of 2018-2023. This report also includes drug sales forecast for some antiretroviral drugs. Request free Sample of this Report @: http://azothanalytics.com/report/healthcare-pharma/global-antiretroviral-drugs-market-analysis-by-drug-type-multi-class-drugs-combination-drugs-nrti-nnrti-protease-inhibitors-by-region-by-country-drug-forecast-2019-edition-opportunities-and-forecast-2013-2023-r32196
Global epilepsy drugs market is expected to cross US$ 9 Billion landmark by 2025. Epilepsy can develop in both males and females of all races, ethnic backgrounds and ages. It affects around 65 Million people globally. United States has around 3.4 Million epilepsy patients; among them around 470 Thousands are children. Renub Research report titled “Epilepsy Drugs Market by Country, Drugs, Treatment Drugs Generation (First, Second, Third), Company & Forecast” provides Global Epilepsy Drugs Market. Access full Research: https://www.renub.com/epilepsy-drugs-market-p.php
According to a report published by Renub Research, Global Epilepsy Drugs Market is anticipated to be more than USD 9 Billion opportunity for pharmaceutical companies by 2025. Epilepsy drugs are generally termed as anti-seizure or anticonvulsants drugs which are used for the symptomatic treatment of epilepsy. Epilepsy drugs act as a mood stabilizers and so it is used in the treatment of bipolar disorder or neuropathic pain. For More Information: https://www.renub.com/global-epilepsy-drugs-market-nd.php
The major players in the global Pharmaceutical Drugs Market are Novartis AG, Sanofi S.A., Pfizer Inc., Gilead Sciences, Inc. Read More @ https://bit.ly/36RNMDr
According to #TechSci Research report on Global Osteoporosis Drugs Market stood at USD13.36 billion in 2020 and is projected to grow at a CAGR of 6.83% to cross USD20.17 billion by 2026. Gain More Insight: https://bit.ly/3IB6OPe Get Sample Report: https://bit.ly/3Dxysc8 Press Release: https://bit.ly/3pIWewK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
At present, incentives for drug development provided by government authorities in various countries are encouraging pharmaceutical companies to develop orphan drugs. For instance, the United States Food and Drug Administration (USFDA) offers benefits such as fast-track approval, protocol assistance, waiver of fees and marketing exclusivity to manufacturers, facilitating the development and commercialization of diagnostic tools and treatments devoted to rare diseases. For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Bharat Book presents the report on “Global Drug Abuse Testing Market”(https://www.bharatbook.com/healthcare-market-research-reports-802983/global-drug-abuse-testing-development-demand-.html). This report contains an analysis of drug of abuse testing market based on the type of test conducted, sample used for testing and geographical analysis, with a brief on testing technologies.
According to Renub Research analysis Global Diabetes Drug Market will be US$ 78.10 Billion by 2026. Forecast for By Disease, Oral Therapy (2020 - 2026)
HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015. Read this Research Report here:- https://www.alliedmarketresearch.com/hiv-drugs-market
According to Renub Research Global Drug Abuse Testing Market will surpass US$ 5 Billion US$ by the year-end of 2025. Forecast by Products & Region (2019 -2025)
Get Drug Abuse Test Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, Future Demand, 2012 - 2020 market research report Published by Allied Market Research. The Report is available at $4515 for Single User Request For Sample Research Report For Biobanks market @ http://www.bigmarketresearch.com/drug-abuse-testing-market
Analyze Future: Osteoporosis Drugs Markets in China To get More Details @ http://www.analyzefuture.com/osteoporosis-drugs-in-china-market China's demand for Osteoporosis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
iGATE Research has released a research report on “Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=136 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
According to a latest research by the company, the global corticosteroid psoriasis drugs treatment market is expected to account for over US$ 6,509 Mn in terms of value by 2028 end.
According to Renub Research analysis Global Hepatitis C Drugs Market would be US$ 5.9 Billion by 2025. Forecast By Regions & Distribution Channels. Call Us : +1 678-302-0700
24 Market Reports provides a complete data analysis of Global Anti-Infective Drugs Sales Market Report 2017.with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. Global AntiInfective Drugs market competition by top manufacturers/players, with AntiInfective Drugs sales volume, Price USD/MT, revenue Million USD and market share for each manufacturer/player; the top players including GlaxoSmithKline Merck Pfizer Novartis AG Gilead Sciences Abbott
Analyze Future: Anesthetic Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/anesthetic-drugs-in-china-market China's demand for Anesthetic Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Oncology Drugs Market is Expected to Reach $111.9 Billion, Globally, by 2020. Read more at: https://www.alliedmarketresearch.com/oncology-cancer-drugs-market Augmentation in the prevalence and incidence rate of various cancers, growing popularity of biological and targeted modalities, along with the patent expiration of major cancer drugs are expected to drive the growth of global oncology drugs market. However, high initial capital investment in new drug development, long-term side effects associated with chemotherapy, and high cost of advanced therapies (targeted and immunotherapies) would limit the growth of the market.
Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.
According to the latest report by Renub Research, titled "Diabetes Drug Market Global & Forecast By Disease, Oral Therapy, Injection, Insulin, Regions, Company" Diabetes drugs are used to treat pre-diabetes and diabetes mellitus type 2 by controlling the blood glucose level of the body. There are different classes of medicine for the treatment of this diabetes, which are given to patients through oral, intravenous, and subcutaneous routes. According to Renub Research analysis, Global Diabetes Drug Market is forecasted to be US$ 78.10 Billion by 2026. This growth is due to the rising number of diabetes patients worldwide, increasing per capita income. Another reason is with the use of machines; people are following a sedentary lifestyle, which leads to obesity, a decline of physical activity, and consumption of unhealthy meals. Besides, growth in the ageing population is also one of the other reason.